Tri-Institutional MD-PhD Program

Student Publications

2022

Liao J, Nishath T, Thevuthasan S, Nieblas-Bedolla E, Christophers B, Starks H, Jackson M, Pagalilauan G. 2022. Race/Ethnicity Trends Among U.S. Internal Medicine Residency Applicants and Matriculants: A Cross-Sectional Study.. Ann Intern Med.

2022

Gupta A, Smith P, Bournazos S, Ravetch JV. 2022. A novel mouse strain optimized for chronic human antibody administration.. Proc Natl Acad Sci U S A. 119(10):e2123002119.

2022

Koschitzky M, Navrazhina K, Garshick MS, Gonzalez J, Han J, Garcet S, Krueger JG. 2022. Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris.. Exp Dermatol.

2022

Abuhashem A, Lee AS, Joyner AL, Hadjantonakis A-K. 2022. Rapid and efficient degradation of endogenous proteins in vivo identifies stage-specific roles of RNA Pol II pausing in mammalian development.. Dev Cell.

2022

Deshpande AS, Ulahannan N, Pendleton M, Dai X, Ly L, Behr JM, Schwenk S, Liao W, Augello MA, Tyer C et al.. 2022. Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencing.. Nat Biotechnol.

2022

Kingery JR, Safford MM, Martin P, Lau JD, Rajan M, Wehmeyer GT, Li HA, Alshak MN, Jabri A, Kofman A et al.. 2022. Health Status, Persistent Symptoms, and Effort Intolerance One Year After Acute COVID-19 Infection.. J Gen Intern Med.

2022

d'Andrea FB, Poulton NC, Froom R, Tam K, Campbell EA, Rock JM. 2022. The essential M. tuberculosis Clp protease is functionally asymmetric in vivo.. Sci Adv. 8(18):eabn7943.

2022

Griswold AR, Huang H-C, Bachovchin DA. 2022. The NLRP1 Inflammasome Induces Pyroptosis in Human Corneal Epithelial Cells.. Invest Ophthalmol Vis Sci. 63(3):2.

2022

Rajappa P, Eng KW, Bareja R, Bander ED, Yuan M, Dua A, Maachani UBhanu, Snuderl M, Pan H, Zhang T et al.. 2022. Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors.. Neurooncol Adv. 4(1):vdac031.

2022

Navrazhina K, Frew JW, Grand D, Williams SC, Hur H, Gonzalez J, Garcet S, Krueger JG. 2022. IL-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.. Br J Dermatol.

2022